Towards the Stable Chelation of Radioantimony(V) for Targeted Auger Theranostics
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202423878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Aeli P Olson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, 53705, United States. Hauptthemen laut MEDLINE: Chelating Agents, Antimony, Theranostic Nanomedicine, Radiopharmaceuticals. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Workforce Development for Teachers and Scientists, NIH HHS.
Abstract (Originalsprache)
Antimony‐119 ( 119 Sb) is one of the most attractive Auger‐electron emitters identified to date, but it remains practically unexplored for targeted radiotherapy because no chelators have been identified to stably bind this metalloid in vivo. In a departure from current studies focused on chelator development for Sb(III), we explore the chelation chemistry of Sb(V) using the tris‐catecholate ligand TREN‐CAM. Through a combination of radiolabeling, spectroscopic, solid‐state, and computational studies, the radiochemistry and structural chemistry of TREN‐CAM with 1XX/nat Sb(V) were established. The resulting [ 1XX Sb]Sb–TREN‐CAM complex remained intact for several days in human serum, signifying high stability under biological conditions. Finally, the first in vivo single photon emission computed tomography and positron emission tomography imaging studies were carried out using 117 Sb, the diagnostic analogue of 119 Sb. These studies revealed marked differences in the uptake and distribution of activity in mice administered unchelated [ 117 Sb]Sb(OH) 6 – versus [ 117 Sb]Sb–TREN‐CAM, suggesting that 117 Sb is largely retained by TREN‐CAM over the time course of the study. Collectively, these findings demonstrate the most physiologically stable complex of no‐carrier‐added 1XX Sb yet reported, offering new promise for the clinical implementation of radioantimony in nuclear medicine. Our results also establish the feasibility of 117 Sb as an elementally matched partner to 119 Sb for theranostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, 53705, United States.
- Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, 37831, United States.
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, 53705, United States.
- Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, 15260.
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, 37831, United States.
- Radioisotope Science and Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, 37831, United States.
ORCID-Profile: Nikki A Thiele
Förderung
- NCI NIH HHS
- Workforce Development for Teachers and Scientists
- NIH HHS
- Office of Isotope R and D and Production
- Office of Isotope Research and Development and Production
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Olson, A. P., Schrage, B. R., Islam, M. F., Fletcher, L. S., Verich, F., Dierolf, M. A., Aluicio-Sarduy, E., Becker, K. V., Driscoll, D. M., Girish, N., Simms, M. E., Kertesz, V., White, F. D., Boros, E., Ivanov, A. S., Engle, J. W., & Thiele, N. A. (2025). Towards the Stable Chelation of Radioantimony(V) for Targeted Auger Theranostics. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202423878
Vancouver
Olson AP, Schrage BR, Islam MF, Fletcher LS, Verich F, Dierolf MA, et al. Towards the Stable Chelation of Radioantimony(V) for Targeted Auger Theranostics. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202423878
BibTeX
@article{Olson2025,
author = {Olson, Aeli P and Schrage, Briana R and Islam, Md Faizul and Fletcher, Lesta S and Verich, Francesca and Dierolf, Morgan A and Aluicio-Sarduy, Eduardo and Becker, Kaelyn V and Driscoll, Darren M and Girish, Nidhi and Simms, Megan E and Kertesz, Vilmos and White, Frankie D and Boros, Eszter and Ivanov, Alexander S and Engle, Jonathan W and Thiele, Nikki A},
title = {Towards the Stable Chelation of Radioantimony(V) for Targeted Auger Theranostics},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202423878}
}
EUVIMED